Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase.

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 23, Issue 12, 2004, Pages 1696-1699

  Zhang, Guo Cai ^a   Zheng, Dong ^a   Li, Qun Hua ^a   Li, Xiao Hu ^a   Cai, Cheng Cai ^a   Luo, Shao Kai ^a   Li, Juan ^a   Peng, Ai Hua ^a   Tong, Xiu Zhen ^a   Tan, En Xun ^a   Hong, Wen De ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL TYROSINE KINASE; BCR-ABL TYROSINE KINASE; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CHRONIC MYELOID LEUKEMIA; DRUG ANTAGONISM; DRUG RESISTANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; REMISSION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BLAST CRISIS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE;

EID: 27644445483     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)